Pricing Log in Create free account
Friday 6 November 2026 Export GRAL’s income statement to Excel — free account

GRAIL, Inc.

GRAL Healthcare Diagnostics & Research

GRAIL, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $147.2 million, up 17.2% from fiscal 2024.

Revenue
+3.71%
EPS
+10.2%
Free cash flow
−24.9%

Quarter to September 2026, against a year earlier

124.40 19.26 −13.41%
Market cap
$5.3B
P/E
0.0×
Fwd P/E
−14.5×
Dividend yield
—
F-score
6/9
Altman Z
0.37
Beneish M
n/a
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

GRAIL, Inc. (GRAL) Book value per share

Alert me on Book value per share

GRAIL, Inc.'s book value per share at the end of fiscal 2025 was 70.1×, down 10.6% from 78.5× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 52.5×. GRAIL, Inc. ranks 8th of 49 Diagnostics & Research companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 70.1× (10.62%)
FY2024 78.5× (33.18%)
FY2023 117× —
FY2022 0.0× —

Quarterly newest first

Period Book value per share Change
Sep 2026 52.5× (11.07%)
Jun 2026 59.0× (4.15%)
Mar 2026 61.5× (12.27%)
Dec 2025 70.1× 13.11%
11 more quarters

Book value per share against peers

Company Book value per share
ICLR ICON PLC compare 119×
GRAL GRAIL, Inc. 52.5×
RDNT RadNet, Inc. compare 17.9×
VCYT Veracyte, Inc. compare 17.8×
QGEN QIAGEN N.V. compare 16.3×
CDNA CareDx, Inc. compare 9.0×
SHC Sotera Health Company compare 2.6×
ADPT Adaptive Biotechnologies Corporation compare 1.1×
BLLN BillionToOne, Inc. compare 0.0×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on GRAL